Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Reduction in YEllow Plaque by Aggressive Lipid LOWering Therapy (YELLOW)

This study has been completed.
Information provided by (Responsible Party):
Annapoorna Kini, Mount Sinai School of Medicine Identifier:
First received: March 28, 2012
Last updated: February 10, 2015
Last verified: February 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2012
  Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):